Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents

NCT03864263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-07-08

No results posted yet for this study

Summary

Hepatitis B virus (HBV) infection is a major public health problem facing the world, with more than 2 billion people infected with HBV. There are more than 400 million chronic carriers, and 75% of carriers live in the Asia Pacific region.

The mother-to-child transmission route of hepatitis B virus is recognized as one of the most important routes of transmission, and recent studies have found that fathers who are carriers of HBV may also be one of the risk factors for HBV infection in children, but as far as the investigators know. Therefore, as a high-population area in China, the purpose of this study is to investigate the prevalence of HBV infection in this population.

Conditions

  • Hepatitis b Virus Infection

Interventions

OTHER

Sponsors & Collaborators

  • Qiu Li

    lead OTHER

Principal Investigators

  • Yao Zhao · Chongqing Children's Hospital of Chongqing Medical University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-04
Primary Completion
2020-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03864263 on ClinicalTrials.gov